DILH
SGYP

Dai-ichi Life Holdings’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Dai-ichi Life Holdings’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-147,937
Closed -$815K – 523
2016
Q3 		$815K Buy
+147,937
New +$693K 0.02% 421

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dai-ichi Life Holdings's SGYP Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 147,937 shares — an estimated $815K sold.

Dai-ichi Life Holdings first reported a position in SGYP in Q3 2016 and held it in 1 quarter. The position peaked at $815K in Q3 2016. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 147,937 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $815K.
  • Dai-ichi Life Holdings first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2016 and held it in 1 quarter.
  • Dai-ichi Life Holdings's Synergy Pharmaceuticals, Inc Common Stock position peaked at $815K in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.